Tokyo, April 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061264) titled 'A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan' on April 16.
Study Type:
Observational
Primary Sponsor:
Institute - Eisai Co., Ltd.
Condition:
Condition - MCI due to Alzheimer's disease (AD) or Mild AD dementia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to quantify the factors and preferences influencing treatment selection for mild cognitive impairment and mild dementia due to Alzheimer's disease, expressed as utility values derived from the value judgments of the general population.
B...